Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022;90(2):461-473.
doi: 10.3233/JAD-220755.

Cognitive Resilience in Brain Health and Dementia Research

Affiliations
Review

Cognitive Resilience in Brain Health and Dementia Research

Mahesh S Joshi et al. J Alzheimers Dis. 2022.

Abstract

With the expected rise in Alzheimer's disease and related dementias (ADRD) in the coming decades due to the aging population and a lack of effective disease-modifying treatments, there is a need for preventive strategies that may tap into resilience parameters. A wide array of resilience strategies has been proposed including genetics, socioeconomic status, lifestyle modifications, behavioral changes, and management of comorbid disease. These different strategies can be broadly classified as distinguishing between modifiable and non-modifiable risk factors, some of which can be quantified so that their clinical intervention can be effectively accomplished. A clear shift in research focus from dementia risk to addressing disease resistance and resilience is emerging that has provided new potential therapeutic targets. Here we review and summarize the latest investigations of resilience mechanisms and methods of quantifying resilience for clinical research. These approaches include identifying genetic variants that may help identify novel pathways (e.g., lipid metabolism, cellular trafficking, synaptic function, inflammation) for therapeutic treatments and biomarkers for use in a precision medicine-like regimen. In addition, innovative structural and molecular neuroimaging analyses may assist in detecting and quantifying pathological changes well before the onset of clinical symptoms setting up the possibility of primary and secondary prevention trials. Lastly, we summarize recent studies demonstrating the study of resilience in caregivers of persons living with dementia may have direct and indirect impact on the quality of care and patient outcomes.

Keywords: Alzheimer’s disease; biomarkers; brain health; cognition; cognitive reserve; dementia; neuroimaging; resilience.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Factors with positive and negative impact on cognitive resilience. The positive factors include cognitive reserve (education and occupation), positive lifestyles (diet, exercise, and cognitive activity), positive behaviors (mindfulness, optimism, and self-sufficiency), genetics (kdm6a, TREM2), greenspace (early and mid-life exposure to natural greenery), and socio-demographics (younger and high income). The negative factors are vascular risk factors (hypertension, diabetes, and obesity), negative lifestyles (head injury, smoking, and alcohol consumption), negative behaviors (depression and anxiety), genetics (MS4A6A, BDNF), co-morbidities (multiple medical conditions), and socio-demographics (low income, old age, racial/ethnic differences).

Similar articles

Cited by

References

    1. (2022) 2022 Alzheimer’s disease facts and figures. Alzheimers Dement 18, 700–789. - PubMed
    1. Prince M, Guerchet M, Prina M (2013) The Global Impact of Dementia 2013-2050. Alzheimer’s Disease International, London.
    1. Galvin JE (2017) Prevention of Alzheimer’s disease: Lessons learned and applied. J Am Geriatr Soc 65, 2128–2133. - PMC - PubMed
    1. Hodes JF, Oakley CI, O’Keefe JH, Lu P, Galvin JE, Saif N, Bellara S, Rahman A, Kaufman Y, Hristov H, Rajji TK, Fosnacht Morgan AM, Patel S, Merrill DA, Kaiser S, Melendez-Cabrero J, Melendez JA, Krikorian R, Isaacson RS (2018) Alzheimer’s “prevention” vs. “risk reduction": Transcending semantics for clinical practice. Front Neurol 9, 1179. - PMC - PubMed
    1. Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimaki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbaek G, Teri L, Mukadam N (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396, 413–446. - PMC - PubMed

Publication types